Self-renewal as a therapeutic target in human colorectal cancer

Cited by (502)

Items 201–300 of 502

1. A highly potent small-molecule antagonist of exportin-1 selectively eliminates CD44+CD24- enriched breast cancer stem-like cells
   Caigang Liu, Yixiao Zhang, Jiujiao Gao, Qi Zhang, Lisha Sun, Qingtian Ma, Xinbo Qiao, Xinnan Li, Jinchi Liu, Jiawen Bu et al. · 2022 · Drug Resistance Updates
2. Bmi1 is required for the initiation of pancreatic cancer through an Ink4a-independent mechanism
   Filip Bednar, Heather K. Schofield, Meredith A. Collins, Wei Yan, Yaqing Zhang, Nikhil Shyam, Jaime A. Eberle-Singh, Luciana L. Almada, Kenneth P. Olive, Nabeel M. Bardeesy et al. · 2015 · Carcinogenesis
3. BCL-3 promotes a cancer stem cell phenotype by enhancing β-catenin signalling in colorectal tumour cells
   Danny Legge, Alex P. Shephard, T J Collard, Alexander Greenhough, A Chambers, Richard W. E. Clarkson, Christos Paraskeva, Ann Caroline Williams · 2019 · Disease Models & Mechanisms
4. Tumor microenvironment-based screening repurposes drugs targeting cancer stem cells and cancer-associated fibroblasts
   Pei-Jung Lee, Chao‐Chi Ho, Hao H. Ho, Wan-Jiun Chen, Chiu-Hua Lin, Yi‐Hua Lai, Yi‐Chen Juan, Wen-Chung Chu, Jia-Hua Lee, Sheng‐Fang Su et al. · 2021 · Theranostics
5. Role of exosomal miRNA in chemotherapy resistance of Colorectal cancer: A systematic review
   Masomeh Maleki, Asal Golchin, Samira Javadi, Nafiseh Khelghati, Pejman Morovat, Z. Asemi, Forough Alemi, Mostafa Vaghari-Tabari, B. Yousefi, M. Majidinia · 2021 · Chemical Biology and Drug Design
6. Up-regulation of stem cell markers by P21-activated kinase 1 contributes to 5-fluorouracil resistance of colorectal cancer
   Nhi Thao Huynh, Arthur Shulkes, Graham S. Baldwin, Hong Zhen He · 2016 · Cancer Biology & Therapy
7. Chemical suppression of specific C-C chemokine signaling pathways enhances cardiac reprogramming
   Yijing Guo, Ienglam Lei, Shuo Tian, Wenbin Gao, Hacer Karataş, Yangbing Li, Shaomeng Wang, Liu Liu, Zhong Wang · 2019 · Journal of Biological Chemistry
8. Dnajb8, a Member of the Heat Shock Protein 40 Family Has a Role in the Tumor Initiation and Resistance to Docetaxel but Is Dispensable for Stress Response
   Masamichi Yamashita, Yoshihiko Hirohashi, Toshihiko Torigoe, Hiroki Kusumoto, Aiko Murai, Tomohiro Imagawa, Noriyuki Sato · 2016 · PLoS ONE
9. MDR1 mediated chemoresistance: BMI1 and TIP60 in action
   Soumyajit Banerjee Mustafi, Prabir Kumar Chakraborty, Sarwat Naz, Shailendra Kumar Dhar Dwivedi, Mark Street, Rumki Basak, Da Yang, Kai Ding, Priyabrata Mukherjee, Resham Bhattacharya · 2016 · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms
10. A novel BMI-1 inhibitor QW24 for the treatment of stem-like colorectal cancer
    Jinhua Wang, Yajing Xing, Yingying Wang, Yundong He, Liting Wang, Shihong Peng, Lian-Fang Yang, Jiuqing Xie, Xiaotao Li, Wen‐Wei Qiu et al. · 2019 · Journal of Experimental & Clinical Cancer Research
11. Polycomb-group proteins in the initiation and progression of cancer
    Xiujuan Zhao, Xudong Wu · 2021 · Journal of genetics and genomics/Journal of Genetics and Genomics
12. BMI-1 regulates DNA end resection and homologous recombination repair
    Amira Mohammed Fitieh, Andrew J. Locke, Fatemeh Mashayekhi, Fajr Khaliqdina, Ajit Kumar Sharma, Ismail Hassan Ismail · 2022 · Cell Reports
13. Targeted Degradation of PRC1 Components, BMI1 and RING1B, via a Novel Protein Complex Degrader Strategy
    Kwang‐Su Park, Lihuai Qin, Md Kabir, Kaixiu Luo, Brandon Dale, Yue Zhong, Arum Kim, Gang Greg Wang, H. Ümit Kanıskan, Jian Jun Jin · 2023 · Advanced Science
14. Pharmacological DNA demethylation: Implications for cancer immunotherapy
    David Roulois, Helen Loo Yau, Daniel Diniz De Carvalho · 2015 · OncoImmunology
15. The Impact of the Gut Microbiome on Colorectal Cancer
    Charles Maisonneuve, Thergiory Irrazábal, Alberto Martín, Stephen E. Girardin, Dana J. Philpott · 2017 · Annual Review of Cancer Biology
16. Epigenetic Modifiers in Normal and Malignant Hematopoiesis
    Jessica N. Haladyna, Taylor Yamauchi, Tobias Neff, Kathrin Maria Bernt · 2015 · Epigenomics
17. G9a/RelB regulates self-renewal and function of colon-cancer-initiating cells by silencing Let-7b and activating the K-RAS/β-catenin pathway
    Shih-Ting Cha, Ching‐Ting Tan, Cheng‐Chi Chang, Chia‐Yu Chu, Wei-Jiunn Lee, Been-Zen Lin, Ming‐Tsan Lin, Min‐Liang Kuo · 2016 · Nature Cell Biology · Retracted
18. BMI1 Drives Metastasis of Prostate Cancer in Caucasian and African-American Men and Is A Potential Therapeutic Target: Hypothesis Tested in Race-specific Models
    Arsheed Ahmad Ganaie, Firdous H. Beigh, Matteo Astone, Marina G. Ferrari, Raihana Maqbool, Syed Umbreen, Aijaz Parray, Hifzur Rahman Siddique, Tabish Hussain, Paari J Murugan et al. · 2018 · Clinical Cancer Research
19. Cancer of unknown primary stem-like cells model multi-organ metastasis and unveil liability to MEK inhibition
    Federica Verginelli, Alberto Maria Pisacane, Gennaro Gambardella, Antonio D’Ambrosio, Ermes Candiello, Marco Ferrio, Mara Panero, Laura Casorzo, Silvia Benvenuti, Eliano Cascardi et al. · 2021 · Nature Communications
20. MYSM1 inhibits human colorectal cancer tumorigenesis by activating miR-200 family members/CDH1 and blocking PI3K/AKT signaling
    Xu Chen, Wei Wang, Yufang Li, Yi Huo, Han Zhang, Fan Feng, Wenjin Xi, Tianze Zhang, Jinjian Gao, Fan Yang et al. · 2021 · Journal of Experimental & Clinical Cancer Research
21. The Potential of Wnt Signaling Pathway in Cancer: A Focus on Breast Cancer
    NanditaR Ghosh, MahnazM Kazi, TruptiI Trivedi, ToralP Kobawala · 2016 · Cancer translational medicine
22. The polycomb group protein BMI-1 inhibitor PTC-209 is a potent anti-myeloma agent alone or in combination with epigenetic inhibitors targeting EZH2 and the BET bromodomains
    Mohammad Alzrigat, Alba Atienza Párraga, Muntasir Mamun Majumder, Anqi Ma, Jian Jun Jin, Anders Österborg, Hareth Nahi, Kenneth Nilsson, Caroline Akemi Heckman, Fredrik G. Oberg et al. · 2017 · Oncotarget
23. Identification of a targetable KRAS-mutant epithelial population in non-small cell lung cancer
    Giorgia Maroni, Mahmoud Adel Bassal, Indira Krishnan, Chee Wai Fhu, Virginia Savova, Rapolas Žilionis, Valerie A. Maymi, Nicole Pandell, Eva Csizmadia, Junyan Zhang et al. · 2021 · Communications Biology
24. Ubiquitin-specific peptidase 5 facilitates cancer stem cell-like properties in lung cancer by deubiquitinating β-catenin
    Chia-Hao Tung, Jiaen Wu, Meng‐Fan Huang, Wen-Lung Wang, Yi-Ying Wu, Yao-Tsung Tsai, Xiu-Rui Hsu, Sheng‐Hsiang Lin, Yuh‐Ling Chen, Tse-Ming Hong · 2023 · Cancer Cell International
25. Synthesis and Characterization of Novel BMI1 Inhibitors Targeting Cellular Self-Renewal in Hepatocellular Carcinoma
    Monica Bartucci, Mohamed S. Hussein, Eric Huselid, Kathleen Flaherty, Michele Patrizii, Saurabh V. Laddha, Cindy Kui, Rachel A. Bigos, John Gilleran, Mervat El‐Ansary et al. · 2017 · Targeted Oncology
26. Targeted therapy against cancer stem cells
    Tao Yang, Kiera Rycaj · 2015 · Oncology Letters
27. Preclinical activity of the novel B‐cell‐specific Moloney murine leukemia virus integration site 1 inhibitor PTC ‐209 in acute myeloid leukemia: Implications for leukemia therapy
    Yuki Nishida, Aya Maeda, Dhruv Chachad, Jo Ishizawa, Yi Hua Qiu, Steven Mitchell Kornblau, Shinya H Kimura, Michael Andreeff, Kensuke Kojima · 2015 · Cancer Science
28. The nucleosome: orchestrating DNA damage signaling and repair within chromatin
    Poonam Agarwal, Kyle M. Miller · 2016 · Biochemistry and Cell Biology
29. BMI1 is directly regulated by androgen receptor to promote castration-resistance in prostate cancer
    Sen Lin Zhu, Dongyu Zhao, Chao Li, Qiaqia Li, Weihua Jiang, Qipeng Liu, Rui Wang, Ladan Fazli, Yinan Li, Lili Zhang et al. · 2019 · Oncogene
30. BMI1 maintains the Treg epigenomic landscape to prevent inflammatory bowel disease
    Michelle M. Gonzalez, Adebowale O. Bamidele, Phyllis A. Svingen, Mary R. Sagstetter, Thomas C. Smyrk, Joseph M. Gaballa, Feda H. Hamdan, Robyn Laura Kosinsky, Hunter R. Gibbons, Zhifu Sun et al. · 2021 · Journal of Clinical Investigation
31. PLK1 Inhibition Down-regulates Polycomb Group Protein BMI1 via Modulation of the miR-200c/141 Cluster
    Manjari Dimri, Joon‐Ho Cho, Mingu Kang, Goberdhan P. Dimri · 2014 · Journal of Biological Chemistry
32. CUL4B contributes to cancer stemness by repressing tumor suppressor miR34a in colorectal cancer
    Yanjun Li, Huili Hu, Yuxing Wang, Yujia Fan, Yang� Yang, Beibei Guo, Xueyong Xie, Jiabei Lian, Baichun Jiang, Bo Han et al. · 2020 · Oncogenesis
33. Large variety in a panel of human colon cancer organoids in response to EZH2 inhibition
    Martijn A. J. Koppens, Gergana Bounova, Paulien Cornelissen‐Steijger, Nienke de Vries, Owen James Sansom, Lodewyk F.A. Wessels, Maarten van Lohuizen · 2016 · Oncotarget
34. BMI1, a new target of CK2α
    Soumyajit Banerjee Mustafi, Prabir Kumar Chakraborty, Shailendra Kumar Dhar Dwivedi, Kai Ding, Katherine Marie Moxley, Priyabrata Mukherjee, Resham Bhattacharya · 2017 · Molecular Cancer
35. Aldehyde dehydrogenase 1A1 (ALDH1A1) expression by immunohistochemistry is associated with chemo-refractoriness in patients with high-grade ovarian serous carcinoma
    Madhuchhanda Roy, Joseph P. Connor, Ahmed Al‐Niaimi, Stephen L. Rose, Aparna Mahajan · 2017 · Human Pathology
36. Identification of new hypoxia‐regulated epithelial‐mesenchymal transition marker genes labeled by H3K4 acetylation
    Jian‐Qiu Wang, Feng‐Qin Yan, Lihui Wang, Wen‐Juan Yin, Ting‐Yu Chang, Junping Liu, Kou‐Juey Wu · 2019 · Genes Chromosomes and Cancer
37. BMI1 Inhibitors Down-regulate NOTCH Signaling and Suppress Proliferation of Acute Leukemia Cells
    Mika Ohtaka, Mai Itoh, Shuji Tohda · 2017 · Anticancer Research
38. Inhibition of protein tyrosine phosphatase receptor type F suppresses Wnt signaling in colorectal cancer
    Tong Gan, Ashley T. Stevens, Xiaopeng Xiong, Yang‐An Wen, Trevor N. Farmer, Austin T. Li, Payton D. Stevens, Sanam Golshani, Heidi L. Weiss, Bernard Mark Evers et al. · 2020 · Oncogene
39. SOX9 Triggers Different Epithelial to Mesenchymal Transition States to Promote Pancreatic Cancer Progression
    Estefanía Carrasco‐García, Lidia Lopez, Verónica Moncho-Amor, Fernando Carazo, Paula Aldaz, Manuel Collado, Donald M. Bell, Ayman Gaafar, Eva Karamitopoulou, Alexandar Tzankov et al. · 2022 · Cancers
40. Bmi1-positive cells in the lingual epithelium could serve as cancer stem cells in tongue cancer
    Toshihiro Tanaka, Naho Atsumi, Naohiro Nakamura, Hirotsugu Yanai, Yoshihiro Komai, Taichi Omachi, Kiyomichi Tanaka, Kazuhiko Ishigaki, Kazuho Saiga, Haruyuki Ohsugi et al. · 2016 · Scientific Reports
41. BMI1 in the heart: Novel functions beyond tumorigenesis
    Dan Yang, Hanqing Liu, Zheng Yang, Di Fan, Qizhu Tang · 2021 · EBioMedicine
42. Concurrent targeting of BMI1 and CDK4/6 abrogates tumor growth in vitro and in vivo
    Ramesh Elango, Radhakrishnan Vishnubalaji, Muthurangan Manikandan, Sarah Binhamdan, Abdulaziz Siyal, Yasser A. Alshawakir, Musaad Abdulaziz Alfayez, Abdullah M. Aldahmash, Nehad M. Alajez · 2019 · Scientific Reports
43. Treatment of LS174T colorectal cancer stem-like cells with n-3 PUFAs induces growth suppression through inhibition of survivin expression and induction of caspase-3 activation
    Mohammad Reza Sam, Parinaz Ahangar, Vahid Nejati, Reza Habibian · 2015 · Cellular Oncology
44. Polycomb group proteins in cancer: multifaceted functions and strategies for modulation
    S P Wang, Sandra Carolina Ordonez‐Rubiano, Alisha Dhiman, Guanming Jiao, Brayden P. Strohmier, Casey J. Krusemark, Emily C. Dykhuizen · 2021 · NAR Cancer
45. The evolutionary landscape of PRC1 core components in green lineage
    Donghong Chen, Yong Huang, Ying Ruan, Wen‐Hui Shen · 2016 · Planta
46. The interplay of DNA damage, epigenetics and tumour heterogeneity in driving cancer cell fitness
    Célia D. Rouault, Emmanuelle Charafe‐Jauffret, Christophe Ginestier · 2025 · Nature Communications
47. Personalized treatment for colorectal cancer: novel developments and putative therapeutic strategies
    Jamil Akkad, Sylvia Bochum, Uwe M. Martens · 2015 · Langenbeck s Archives of Surgery
48. Regulated genes in mesenchymal stem cells and gastric cancer
    Shihori Tanabe · 2015 · World Journal of Stem Cells
49. Administration of Hypoxia-Activated Prodrug Evofosfamide after Conventional Adjuvant Therapy Enhances Therapeutic Outcome and Targets Cancer-Initiating Cells in Preclinical Models of Colorectal Cancer
    Haynes, Jennifer, McKee, Trevor D., Haller, Andrew, Wang, Yadong, Leung, Cherry, Gendoo, Deena M.A., Lima-Fernandes, Evelyne, Kreso, Antonija, Wolman, Robin, Szentgyorgyi, Eva et al. · 2018 · Clinical Cancer Research
50. Therapeutic targeting of pancreatic cancer stem cells by dexamethasone modulation of the MKP-1–JNK axis
    Shuhei Suzuki, Masashi Okada, Tomomi Sanomachi, Keita Togashi, Shizuka Seino, Atsushi Satō, Masahiro Yamamoto, Chifumi Kitanaka · 2020 · Journal of Biological Chemistry
51. From Chemotherapy to Combined Targeted Therapeutics: In Vitro and in Vivo Models to Decipher Intra-tumor Heterogeneity
    Guido Gambara, Manuela Gaebler, Ulrich Keilholz, Christian R. A. Regenbrecht, Alessandra Silvestri · 2018 · Frontiers in Pharmacology
52. Identification of CD146 as a marker enriched for tumor-propagating capacity reveals targetable pathways in primary human sarcoma
    Qingxia Wei, Yuning J. Tang, Véronique Voisin, Shingo Sato, Makoto Hirata, Heather Whetstone, Ilkyu Han, Laurie Ailles, Gary D. Bader, Jay Steven Wunder et al. · 2015 · Oncotarget
53. Roles of BMI1 in the Initiation, Progression, and Treatment of Hepatocellular Carcinoma
    Ru Wang, Hengwei Fan, Ming Sun, Zhong‐Wei Lv, Wanwan Yi · 2022 · Technology in Cancer Research & Treatment
54. Reciprocal interplays between MicroRNAs and pluripotency transcription factors in dictating stemness features in human cancers
    Radhakrishnan Vishnubalaji, Hibah Shaath, Monther M Al-Alwan, Essam Mohamed Abdelalim, Nehad M. Alajez · 2022 · Seminars in Cancer Biology
55. Therapeutic potential of cancer stem cells
    Chunguang Yang, Kunlin Jin, Yangping Tong, William Chi Shing Cho · 2015 · Medical Oncology
56. Epigenetic mechanisms of tumorigenicity manifesting in stem cells
    P. X. Tung, Paul S. Knoepfler · 2014 · Oncogene
57. Dendrosomal nanocurcumin and exogenous p53 can act synergistically to elicit anticancer effects on breast cancer cells
    Narges Baghi, Babak Bakhshinejad, Reihaneh Keshavarz, Sadegh Babashah, Majid Sadeghizadeh · 2018 · Gene
58. Bmi-1 Regulates Extensive Erythroid Self-Renewal
    Ah Ram Kim, Jayme Olsen, Samantha J. England, Yu-Shan Huang, Katherine H. Fegan, Luis F. Delgadillo, Kathleen E. McGrath, Paul D. Kingsley, Richard E. Waugh, James Palis · 2015 · Stem Cell Reports
59. Artificial Intelligence in Oncology Drug Discovery and Development
    John W. Cassidy, Belle Taylor · 2020 · IntechOpen eBooks
60. Musarin, a novel protein with tyrosine kinase inhibitory activity from Trametes versicolor, inhibits colorectal cancer stem cell growth
    Yingying He, Shubai Liu, David S. Newburg · 2021 · Biomedicine & Pharmacotherapy
61. Engineering Heterogeneous Tumor Models for Biomedical Applications
    Zhuhao Wu, Danqing Huang, Jinglin Wang, Yuanjin Zhao, Weijian Sun, Xian Shen · 2023 · Advanced Science
62. Silencing BMI1 radiosensitizes human breast cancer cells by inducing DNA damage and autophagy
    James N. Griffith, Daniel Andrade, Meghna Mehta, William L. Berry, Doris M. Benbrook, Natarajan Aravindan, Terence S. Herman, Rajagopal Ramesh, Anupama Munshi · 2017 · Oncology Reports
63. BMI1 activates P-glycoprotein via transcription repression of miR-3682-3p and enhances chemoresistance of bladder cancer cell
    Mingkun Chen, Jun-Hao Zhou, Peng Wang, Yunlin Ye, Yang Liu, Jiawei Zhou, Zijian Chen, Jian-Kun Yang, De-Ying Liao, Zhi-Jian Liang et al. · 2021 · Aging
64. Alantolactone inhibits cervical cancer progression by downregulating BMI1
    Xiaodong Sun, Hongxia Xu, Tianyu Dai, Lixia Xie, Qiang Zhao, Xincai Hao, Yan Sun, Xuanbin Wang, Nan Jiang, Ming Sang · 2021 · Scientific Reports
65. The dopamine transporter antagonist vanoxerine inhibits G9a and suppresses cancer stem cell functions in colon tumors
    Christopher J. Bergin, Aïcha Zouggar, Amanda Mendes da Silva, Tanguy Fenouil, Joshua R. Haebe, Angelique N. Masibag, Gautam Agrawal, Muhammad Sibtain Shah, Tamara Sandouka, Mario Tiberi et al. · 2024 · Nature Cancer
66. BMI1 Is Expressed in Canine Osteosarcoma and Contributes to Cell Growth and Chemotherapy Resistance
    Mehdi Hayat Shahi, Daniel S. York, Regina F. Gandour‐Edwards, Sita S. Withers, Roseline Holt, Robert B. Rebhun · 2015 · PLoS ONE
67. Epigenetic regulation of embryonic stem cell marker miR302C in human chondrosarcoma as determinant of antiproliferative activity of proline-rich polypeptide 1
    Karina A. Galoian, Amir H. Qureshi, Gianluca D’Ippolito, Paul C. Schiller, Marco Molinari, Andrea L. Johnstone, Shaun P. Brothers, Ana Cristina Paz, Harry Thomas Temple · 2015 · International Journal of Oncology
68. Cancer stem cells and autophagy: Facts and Perspectives
    Ahmed Hamaï, Patrice Codogno, Maryam Mehrpour · 2014 · Journal of Cancer Stem Cell Research
69. The Therapeutic Targets of miRNA in Hepatic Cancer Stem Cells
    Sabrina Bimonte, Maddalena Leongito, Antônio Barbieri, Vitale Del Vecchio, Michela Falco, Aldo Giudice, Raffaéle Palaia, Vittorio Albino, Raimondo Di Giacomo, Antonella Petrillo et al. · 2016 · Stem Cells International
70. Mutational Profiles Reveal an Aberrant TGF-β-CEA Regulated Pathway in Colon Adenomas
    Jian Chen, Gottumukkala Subba Raju, Wilma SR Jogunoori, Vipin K. Menon, Avijit Majumdar, Jiun‐Sheng Chen, Young Jin Gi, Yun Seong Jeong, Liem Minh Phan, Mitchell D. Belkin et al. · 2016 · PLoS ONE
71. Inhibition of BMI1, a Therapeutic Approach in Endometrial Cancer
    Megan E. Buechel, Anindya Dey, Shailendra Kumar Dhar Dwivedi, Aleia K. Crim, Kai Ding, Roy Zhang, Priyabrata Mukherjee, Kathleen N. Moore, Liangxian Cao, Arthur A. Branstrom et al. · 2018 · Molecular Cancer Therapeutics
72. Colorectal cancer stem cells properties and features: evidence of interleukin-8 involvement
    Fabiana Conciatori, Chiara Bazzichetto, Italia Falcone, Gianluigi Ferretti, Francesco Cognetti, Michèle Milella, Ludovica Ciuffreda · 2019 · Cancer Drug Resistance
73. Bmi-1: A master regulator of head and neck cancer stemness
    Alexandra E. Herzog, Ritu Somayaji, Jacques Eduardo Nor · 2023 · Frontiers in Oral Health
74. The role of polycomb repressive complexes in biliary tract cancer
    Christian Mayr, Daniel Neureiter, Andrej Wagner, Martin Pichler, Tobias Kiesslich · 2014 · Expert Opinion on Therapeutic Targets
75. Targeting of BMI-1 expression by the novel small molecule PTC596 in mantle cell lymphoma
    Aya Maeda, Yuki Nishida, Marla L. Weetall, Liangxian Cao, Arthur A. Branstrom, Jo Ishizawa, Takenobu Nii, Wendy D. Schober, Yoshiaki Abe, Kosei Matsue et al. · 2018 · Oncotarget
76. Combination of BMI1 and MAPK/ERK inhibitors is effective in medulloblastoma
    Sara Badodi, Nicola Pomella, Yau Mun Lim, Sebastian Brandner, Gillian M. Morrison, Steven M. Pollard, Xinyu Zhang, Nicolae Radu Zabet, Silvia Marino · 2022 · Neuro-Oncology
77. Acute myeloid leukemia driven by the CALM-AF10 fusion gene is dependent on BMI1
    Karina Barbosa, Anagha J. Deshpande, Bo-Rui Chen, Anwesha Ghosh, Younguk Sun, Sayantanee Dutta, Marla L. Weetall, Jesse Dixon, Scott A. Armstrong, Stefan K. Bohlander et al. · 2019 · Experimental Hematology
78. 3D microgels to quantify tumor cell properties and therapy response dynamics
    Nila C. Wu, Jose L. Cadavid, Xinzhu Tan, Simon Latour, Stefano Scaini, Priya Makhijani, Tracy L. McGaha, Laurie Ailles, Alison P. McGuigan · 2022 · Biomaterials
79. Targeting cancer stemness mediated by BMI1 and MCL1 for non‐small cell lung cancer treatment
    Erh-Hsuan Lin, Jhen‐Wei Hsu, Ting‐Fang Lee, Chiung‐Fang Hsu, Tsung‐Hsien Lin, Yi‐Hua Jan, Hsiang‐Yi Chang, Chunming Cheng, H.C. Hsu, Wei‐Wei Chen et al. · 2022 · Journal of Cellular and Molecular Medicine
80. Characteristic Analysis of Featured Genes Associated With Stemness Indices in Colorectal Cancer
    Yongqu Lu, Xin Zhou, Zhenzhen Liu, Wendong Wang, Fei Li, Wei Fu · 2020 · Frontiers in Molecular Biosciences
81. Targeting BMI-1 with PLGA–PEG nanoparticle-containing PTC209 modulates the behavior of human glioblastoma stem cells and cancer cells
    Elham Poonaki, Fatemeh Ariakia, Mohammad Jalili‐Nik, Mehdi Shafiee Ardestani, Gholamhossein Tondro, Fariborz Samini, Sepideh Ghasemi, Sajad Sahab Negah, Ali Gorji · 2021 · Cancer Nanotechnology
82. Recent progress on small molecules targeting epigenetic complexes
    Yukihiro Itoh, Yuri Takada, Yasunobu Yamashita, Takayoshi Suzuki · 2022 · Current Opinion in Chemical Biology
83. MiR-218-targeting-Bmi-1 mediates the suppressive effect of 1,6,7-trihydroxyxanthone on liver cancer cells
    Wei-Ming Fu, Lipeng Tang, Xiao Ming Zhu, Yingfei Lu, Yanling Zhang, Wayne Lee, Hua Wang, Yang Yu, Weicheng Liang, Chun‐Hay Ko et al. · 2014 · APOPTOSIS
84. Epigenetic regulators: Polycomb-miRNA circuits in cancer
    Filomena de Nigris · 2016 · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms
85. CDKN2A-independent role of BMI1 in promoting growth and survival of Ph+ acute lymphoblastic leukemia
    Samanta Antonella Mariani, Valentina Minieri, Marco De Dominici, Ilaria Iacobucci, Luke F. Peterson, Bruno Calabretta · 2016 · Leukemia
86. Curcumin Derivative C086 Combined with Cisplatin Inhibits Proliferation of Osteosarcoma Cells
    Xi Jiang, Yulin Huang · 2020 · Medical Science Monitor
87. Long-Distance Repression by Human Silencers: Chromatin Interactions and Phase Separation in Silencers
    Ying Zhang, Yi Xiang See, Vinay Tergaonkar, Melissa J. Fullwood · 2022 · Cells
88. RNF43 induces the turnover of protease‐activated receptor 2 in colon cancer
    Jeetendra Kumar Nag, Priyanga Appasamy, Shoshana Sedley, Hodaya Malka, Tatyana Rudina, Rachel Bar‐Shavit · 2022 · The FASEB Journal
89. Pharmacological targeting of Sam68 functions in colorectal cancer stem cells
    Angelique N. Masibag, Christopher J. Bergin, Joshua R. Haebe, Aïcha Zouggar, Muhammad Sibtain Shah, Tamara Sandouka, Amanda Mendes da Silva, François M. Desrochers, Aube Fournier-Morin, Yannick D. Benoit · 2021 · iScience
90. BMI-1 interacts with sMEK1 and inactivates sMEK1-induced apoptotic cell death
    Boh-Ram Kim, Youngjoo Kwon, Seung Bae Rho · 2016 · Oncology Reports
91. Prognostic and clinicopathological value of Nanog in hepatocellular carcinoma: A meta-analysis
    Chaojie Liang, Kaitong Zhang, Hua Ge, Wěi Li, Guangming Li, Jixiang Wu · 2017 · Clinica Chimica Acta
92. The Pluripotency Network in Colorectal Cancer Pathogenesis and Prognosis: an Update
    Ioannis A. Voutsadakis · 2018 · Biomarkers in Medicine
93. The role of BMI1 in endometrial cancer and other cancers
    Yiting Zhao, Weili Yang, Kaifeng Zheng, Jun Chen, Xiaofeng Jin · 2022 · Gene
94. Advances and perspectives of colorectal cancer stem cell vaccine
    Mei Guo, Jun Dou · 2015 · Biomedicine & Pharmacotherapy
95. Synthesis of Cyanoenone-Modified Diterpenoid Analogs as Novel Bmi-1-Mediated Antitumor Agents
    Lian-Fang Yang, Yajing Xing, Jie-Xin Xiao, Jia Xie, Wei Gao, Jiuqing Xie, Liting Wang, Jinhua Wang, Mingyao Liu, Zhengfang Yi et al. · 2018 · ACS Medicinal Chemistry Letters
96. Protocol for serial organoid formation assay using primary colorectal cancer tissues to evaluate cancer stem cell activity
    Bergin, Christopher J., Benoit, Yannick D. · 2022 · STAR Protocols
97. Know when to fold ‘em: Polycomb complexes in oncogenic 3D genome regulation
    Emma J. Doyle, Lluís Morey, Eric Conway · 2022 · Frontiers in Cell and Developmental Biology
98. The Effect of Analogues of 1α,25-Dihydroxyvitamin D2 on the Regrowth and Gene Expression of Human Colon Cancer Cells Refractory to 5-Fluorouracil
    Jacek Neska, Paweł Swoboda, Małgorzata Przybyszewska, Agnieszka Kotlarz, Narasimha Rao Bolla, Joanna Miłoszewska, Monika Anna Grygorowicz, Andrzej Kutner, Sergiusz Markowicz · 2016 · International Journal of Molecular Sciences
99. Epigenetic regulator BMI1 promotes alveolar rhabdomyosarcoma proliferation and constitutes a novel therapeutic target
    Cara E. Shields, Sindhu Potlapalli, Selma M. Cuya-Smith, Sarah K. Chappell, Dongdong Chen, Daniel Martínez, Jennifer E. Pogoriler, Komal S. Rathi, Shiv A. Patel, Kristianne Michelle Oristian et al. · 2021 · Molecular Oncology
100. Mel-18 negatively regulates stem cell-like properties through downregulation of miR-21 in gastric cancer
     Xiaofeng Wang, Xiaowei Zhang, Rui‐Xi Hua, Yiqun Du, Mingzhu Huang, Yong Liu, Yu Cheng, Weijian Guo · 2016 · Oncotarget